Aygin Bayraktar-Ekincioğlu, PhD, Hacettepe University, Ankara, Turkey, reviews data from a publication on drug-related problems with targeted/immunotherapies at an oncology outpatient clinic, which demonstratde the impact of a clinical pharmacist in an outpatient oncology care setting. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.